Skin-wound healing is a complex and dynamic biological process involving inflammation, proliferation, and remodeling. Recent studies have shown that statins are new therapeutical options because of their actions, such as anti-inflammatory and antioxidant activity, on vasodilation, endothelial dysfunction and neoangiogenesis, which are independent of their lipid-lowering action. Our aim was to investigate the effect of atorvastatin on tissue repair after acute injury in healthy animals. Rats were divided into four groups: placebo-treated (P), topical atorvastatin-treated (AT), oral atorvastatin-treated (AO), topical and oral atorvastatin-treated (ATO). Under anesthesia, rats were wounded with an 8-mm punch in the dorsal region. Lesions were photographed on Days 0, 1, 3, 7, 10, 12, and 14 post-injury and samples taken on Days 1, 3, 7, and 14 for protein-expression analysis of insulin receptor substrate (IRS)-1, phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), glycogen synthase kinase (GSK)-3, endothelial nitric oxide synthase (eNOS), vascular endothelial growth factor (VEGF), extracellular signal-regulated kinase (ERK), interleukin (IL)-10, IL-1β, IL-6, and tumor necrosis factor (TNF)-α. Upon macroscopic examination, we observed significant reductions of lesion areas in groups AT, AO, and ATO compared to the P group. Additionally, AT and AO groups showed increased expression of IRS-1, PI3K, Akt, GSK-3, and IL-10 on Days 1 and 3 when compared with the P group. All atorvastatin-treated groups showed higher expression of IRS-1, PI3K, Akt, GSK-3, IL-10, eNOS, VEGF, and ERK on Day 7. On Days 1, 3, and 7, all atorvastatin-treated groups showed lower expression of IL-6 and TNF-α when compared with the P group. We conclude that atorvastatin accelerated tissue repair of acute lesions in rats and modulated expressions of proteins and cytokines associated with cell-growth pathways.172159168Adami, M., Prudente, A.A.S., Mendes, D.A., Horinouchi, C.D., Cabrini, D.A., Otuki, M.F., Simvastatin ointment, a new treatment for skin inflammatory conditions (2012) Journal of Dermatological Science, 66, pp. 127-135Araújo, F.A., Rocha, M.A., Mendes, J.B., Andrade, S.P., Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1 (2010) Biomedicine & Pharmacotherapy, 64, pp. 29-34Asai, J., Takenaka, H., Hirakawa, S., Sakabe, J., Hagura, A., Kishimoto, S., Katoh, N., Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis (2012) American Journal of Pathology, 181, pp. 2217-2224Bao, P., Kodra, A., Tomic-Canic, M., Golinko, M.S., Ehrlich, H.P., Brem, H., The role of vascular endothelial growth factor in wound healing (2009) Journal of Surgical Research, 153, pp. 347-358Bitto, A., Minutoli, L., Altavilla, D., Polito, F., Fiumara, T., Marini, H., Squadrito, F., Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes (2008) Pharmacological Research, 57, pp. 159-169Bracht, L., Caparroz-Assef, S.M., Magon, T.F., Ritter, A.M., Cuman, R.K., Bersani-Amado, C.A., Topical anti-inflammatory effect of hypocholesterolaemic drugs (2011) Journal of Pharmacological Research, 63, pp. 971-975Calisto, K.L., Carvalho, B.E.M., Ropelle, E.R., Mittestainer, F.C., Camacho, A.C., Guadagnini, D., Saad, M.J., Atorvastatin improves survival in septic rats: Effect on tissue inflammatory pathway and on insulin signaling (2010) PLoS One, 5, p. 14232Danesh, F.R., Kanwar, Y.S., Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy (2004) The FASEB Journal, 18, pp. 805-815Efthymiou, C.A., Mocanu, M.M., Yellon, D.M., Atorvastatin and myocardial reperfusion injury: New pleiotropic effect implicating multiple prosurvival signaling (2005) Journal of Cardiovascular Pharmacology, 45, pp. 247-252Eming, S.A., Krieg, T., Davidson, J.M., Inflammation in wound repair: Molecular and cellular mechanisms (2007) Journal of Investigative Dermatology, 127, pp. 514-525Johansen, O.E., Birkeland, K.I., Jorgensen, E.O., Sorgard, B., Torjussen, B.R., Ueland, T., Gullestad, L., Diabetic foot ulcer burden may be modified by high dose atorvastatin: A 6-month randomized controlled pilot trial (2009) Journal of Diabetes, 1, pp. 182-187Jowkar, F., Namazi, M.R., Statins in dermatology (2010) International Journal of Dermatology, 49, pp. 1235-1243Kaehn, K., An in-vitro model for comparing the efficiency of wound-rinsing solutions (2009) Journal of Wound Care, 18, 232 (234), pp. 229-230Karadeniz Cakmak, G., Irkorucu, O., Ucan, B.H., Emre, A.U., Bahadir, B., Demirtas, C., Comert, M., Simvastatin improves wound strength after intestinal anastomosis in the rat (2009) Journal of Gastrointestinal Surgery, 13, pp. 1707-1716Kwak, B., Mulhaupt, F., Myit, S., Mach, F., Statins as a newly recognized type of immunomodulator (2000) Nature Medicine, 6, pp. 1399-1402Laing, T., Hanson, R., Chan, F., Bouchier-Hayes, D., Effect of pravastatin on experimental diabetic wound healing (2010) Journal of Surgical Research, 161, pp. 336-340Liao, J.K., Laufs, U., Pleiotropic effects of statins (2005) Annual Review of Pharmacology and Toxicology, 45, pp. 89-118Lima, M.H.M., Caricilli, A.M., de Abreu, L.L., Araújo, E.P., Pelegrinelli, F.F., Thirone, A.C.P., Saad, M.J.A., Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: A double-blind placebo-controlled clinical trial (2012) PLoS ONE, 7Pastore, S., Mascia, F., Mariotti, F., Dattilo, C., Mariani, V., Girolomoni, G., ERK1/2 regulates epidermal chemokine expression and skin inflammation (2005) Journal of Immunology, 174, pp. 5047-5056Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited (2008) The FASEB Journal, 22, pp. 659-661Rodionova, E., Conzelmann, M., Maraskovsky, E., Hess, M., Kirsch, M., Giese, T., Luft, T., GSK-3 mediates differentiation and activation of proinflammatory dendritic cells (2007) Blood, 109, pp. 1584-1592Schiefelbein, D., Goren, I., Fisslthaler, B., Schmidt, H., Geisslinger, G., Pfeilschifter, J., Frank, S., Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses (2008) Journal of Biological Chemistry, 283, pp. 15479-15490Stumpf, C., Petzi, S., Seybold, K., Wasmeier, G., Arnold, M., Raaz, D., Garlichs, C.D., Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction (2009) Clinical Science, 116, pp. 45-52Toker, S., Gulcan, E., Cayc, M.K., Olgun, E.G., Erbilen, E., Ozay, Y., Topical atorvastatin in the treatment of diabetic wounds (2009) American Journal of the Medical Sciences, 338, pp. 201-204Van Linthout, S., Riad, A., Dhayat, N., Spillmann, F., Du, J., Dhayat, S., Tschöpe, C., Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy (2007) Diabetologia, 50, pp. 1977-1986Waiczies, S., Prozorovski, T., Infante-Duarte, C., Hahner, A., Aktas, O., Ullrich, O., Zipp, F., Atorvastatin induces T cell anergy via phosphorylation of ERK1 (2005) Journal of Immunology, 174, pp. 5630-5635